# Grifols extends supply agreement with OraSure Technologies

Grifols has restated its 2005 agreement with OraSure Technologies for a five-year extension to supply recombinant antigens for OraSure's OraQuick HCV Rapid Antibody Test.

- Type: Contract
- Announced: 2017-04-24
- Status: announced
- Products: recombinant antigens for HCV, HIV, HBV diagnostic tests
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [OraSure Technologies](https://endata.com/companies/20243.md) (customer)
- [Grifols](https://endata.com/companies/23767.md) (supplier)

## Sources

- [prnewswire.com](https://www.prnewswire.com/news-releases/grifols-strengthens-position-as-global-provider-of-diagnostic-testing-solutions-with-five-year-extension-of-orasure-technologies-agreement-and-a-new-manufacturing-facility-300443749.html), 2017-04-24: "Grifols announces that it has restated its 2005 agreement with OraSure Technologies"

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.